Article metrics

Download PDFPDF

Letter
Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity

 

Online download statistics by month:

Online download statistics by month: September 2022 to May 2024

AbstractFullPdf
Sep 2022753766128
Oct 2022634644346
Nov 2022509491112
Dec 202218017063
Jan 202322321748
Feb 202316215729
Mar 202311511334
Apr 2023867235
May 2023737223
Jun 2023636216
Jul 2023474023
Aug 2023535116
Sep 2023595314
Oct 2023484217
Nov 2023595810
Dec 2023373710
Jan 202431289
Feb 2024444412
Mar 2024363311
Apr 202437348
May 202459467
Total33083230971